Timolol nasal spray (DrugBank: Timolol)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
227 | Osler disease | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02484716 (ClinicalTrials.gov) | June 2015 | 17/6/2015 | Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO) | Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo | Hemorrhagic Hereditary Telangiectasia (HHT) | Drug: Timolol nasal spray;Drug: Placebo nasal spray | Hospices Civils de Lyon | NULL | Completed | 18 Years | N/A | All | 58 | Phase 2 | France |